Literature DB >> 2493327

Osteonectin inhibiting de novo formation of apatite in the presence of collagen.

Y Doi1, R Okuda, Y Takezawa, S Shibata, Y Moriwaki, N Wakamatsu, N Shimizu, K Moriyama, H Shimokawa.   

Abstract

The effect of bone matrix protein of osteonectin on de novo formation of apatite was studied in a wide range of calcium phosphate solutions in the presence of collagen. In every solution, from which amorphous calcium phosphate, octacalcium phosphate, or apatite precipitated as a possible initial phase, osteonectin at concentrations less than 1 microM retarded the precipitation, subsequent transformation to apatite, and ripening crystal growth of apatite. Collagen present as either reconstituted or denatured form had no effect on the osteonectin-associated reactions as well as osteonectin-free reactions, and no structural correlation was observed between collagen fibrils and any of the calcium phosphates that appeared in our system. Direct measurement of free calcium levels in the solutions suggested that the reduction in calcium activity due to complexing with osteonectin hardly explained the inhibitory activity of osteonectin in retarding the formation of apatite. Instead, our transmission electron microscopic (TEM) observation strongly suggested that the primary mechanism for osteonectin to inhibit the formation of apatite is to block growth sites of calcium phosphates nucleated. The apatite thus formed in the presence of osteonectin showed less resolved X-ray diffraction patterns, partly because of smaller crystallites as suggested by TEM.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2493327     DOI: 10.1007/bf02556565

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  38 in total

1.  An electron-microscopic study of the crystalline inorganic component of bone and its relationship to the organic matrix.

Authors:  R A ROBINSON
Journal:  J Bone Joint Surg Am       Date:  1952-04       Impact factor: 5.284

2.  Relation between collagen and mineral salts in bone tissue.

Authors:  A ENGSTROM; B ENGFELDT; R ZETTERSTROM
Journal:  Experientia       Date:  1952-07-15

3.  An electron microscopic study of the formation of amorphous calcium phosphate and its transformation to crystalline apatite.

Authors:  E D Eanes; J D Termine; M U Nylen
Journal:  Calcif Tissue Res       Date:  1973-05-09

4.  The kinetics of mineralization in vitro. I. The nucleation properties of 640-angstrom collagen at 25 degrees.

Authors:  E P Katz
Journal:  Biochim Biophys Acta       Date:  1969-11-11

5.  Hydroxyapatite formation from a hydrated calcium monohydrogen phosphate precursor.

Authors:  M D Francis; N C Webb
Journal:  Calcif Tissue Res       Date:  1971

6.  Crystal growth of bone mineral.

Authors:  W E Brown
Journal:  Clin Orthop Relat Res       Date:  1966 Jan-Feb       Impact factor: 4.176

7.  Isolation and characterization of native adult osteonectin.

Authors:  R W Romberg; P G Werness; P Lollar; B L Riggs; K G Mann
Journal:  J Biol Chem       Date:  1985-03-10       Impact factor: 5.157

8.  Precipitation of calcium phosphates under conditions of double diffusion in collagen and gels of gelatin and agar.

Authors:  B Pokrić; Z Pucar
Journal:  Calcif Tissue Int       Date:  1979-04-17       Impact factor: 4.333

9.  Partition of calcium, phosphate, and protein in the fluid phase aspirated at calcifying sites in epiphyseal cartilage.

Authors:  D S Howell; J C Pita; J F Marquez; J E Madruga
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

10.  An intermediate state in hydrolysis of amorphous calcium phosphate.

Authors:  M S Tung; W E Brown
Journal:  Calcif Tissue Int       Date:  1983-09       Impact factor: 4.333

View more
  14 in total

Review 1.  Modulation of bone calcium-binding sites regulates plasma calcium: an hypothesis.

Authors:  F Bronner; W D Stein
Journal:  Calcif Tissue Int       Date:  1992-06       Impact factor: 4.333

2.  Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins.

Authors:  G K Hunter; P V Hauschka; A R Poole; L C Rosenberg; H A Goldberg
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

3.  The role of osteonectin in human tooth development: an immunohistological study.

Authors:  T Reichert; S Störkel; K Becker; L W Fisher
Journal:  Calcif Tissue Int       Date:  1992-05       Impact factor: 4.333

4.  Sparc protein is required for normal growth of zebrafish otoliths.

Authors:  Young-Jin Kang; Amy K Stevenson; Peter M Yau; Richard Kollmar
Journal:  J Assoc Res Otolaryngol       Date:  2008-09-11

5.  Temporal and spatial expression patterns of biomineralization proteins during early development in the stony coral Pocillopora damicornis.

Authors:  Tali Mass; Hollie M Putnam; Jeana L Drake; Ehud Zelzion; Ruth D Gates; Debashish Bhattacharya; Paul G Falkowski
Journal:  Proc Biol Sci       Date:  2016-04-27       Impact factor: 5.349

6.  Conformational changes of bovine bone osteonectin induced by interaction with calcium.

Authors:  H Takita; Y Kuboki
Journal:  Calcif Tissue Int       Date:  1995-06       Impact factor: 4.333

7.  Fetuin-A/albumin-mineral complexes resembling serum calcium granules and putative nanobacteria: demonstration of a dual inhibition-seeding concept.

Authors:  Cheng-Yeu Wu; Jan Martel; David Young; John D Young
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

8.  Molecular analysis of Xenopus laevis SPARC (Secreted Protein, Acidic, Rich in Cysteine). A highly conserved acidic calcium-binding extracellular-matrix protein.

Authors:  S Damjanovski; F Liu; M Ringuette
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

9.  Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation.

Authors:  G K Hunter; C L Kyle; H A Goldberg
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

10.  Immobilized DPP and other proteins modify OCP formation.

Authors:  Y Doi; T Horiguchi; S H Kim; Y Moriwaki; N Wakamatsu; M Adachi; H Shigeta; S Sasaki; H Shimokawa
Journal:  Calcif Tissue Int       Date:  1993-02       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.